KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Moderna (MRNA) Research & Development: 2016-2024

Historic Research & Development for Moderna (MRNA) over the last 9 years, with Dec 2024 value amounting to $4.5 billion.

  • Moderna's Research & Development fell 29.55% to $801.0 million in Q3 2025 from the same period last year, while for Sep 2025 it was $3.5 billion, marking a year-over-year decrease of 27.93%. This contributed to the annual value of $4.5 billion for FY2024, which is 6.23% down from last year.
  • Latest data reveals that Moderna reported Research & Development of $4.5 billion as of FY2024, which was down 6.23% from $4.8 billion recorded in FY2023.
  • Moderna's 5-year Research & Development high stood at $4.8 billion for FY2023, and its period low was $1.4 billion during FY2020.
  • For the 3-year period, Moderna's Research & Development averaged around $4.2 billion, with its median value being $4.5 billion (2024).
  • As far as peak fluctuations go, Moderna's Research & Development spiked by 176.21% in 2020, and later dropped by 6.23% in 2024.
  • Yearly analysis of 5 years shows Moderna's Research & Development stood at $1.4 billion in 2020, then skyrocketed by 45.33% to $2.0 billion in 2021, then soared by 65.49% to $3.3 billion in 2022, then spiked by 47.04% to $4.8 billion in 2023, then dropped by 6.23% to $4.5 billion in 2024.